patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · antibody
pembrolizumab
Marketedupdated 2mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
Approvedannual revenue · 2024–2024peak $29.5B
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 146 investigational indications.
indications
investigational
NSCLCMelanoma
targets
Programmed cell death protein 1
all catalysts(100)
approval · 100
News(1)
- Merck adds to pharma’s AI push; Roche details MS drug results<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that